2101 FOLFOXIRI versus FOLFOX/FOLFIRI plus Bevacizumab as first-line treatment in metastatic colorectal cancer: A systematic review and network Meta-analysis of phase III study. (September 2015) - Zhang, J.; Deng, Y.; Cai, Y.; Hu, H.; Xiao, J.; Ling, J.